Giorgio Scagliotti

Giorgio Scagliotti

UNVERIFIED PROFILE

Are you Giorgio Scagliotti?   Register this Author

Register author
Giorgio Scagliotti

Giorgio Scagliotti

Publications by authors named "Giorgio Scagliotti"

Are you Giorgio Scagliotti?   Register this Author

100Publications

2734Reads

19Profile Views

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.

J Thorac Oncol 2019 Aug 9;14(8):1458-1471. Epub 2019 May 9.

Department of Oncology, University of Torino, Torino, Italy; Interdepartmental Center "G. Scansetti" for the Study of Asbestos and Other Toxic Particulates, University of Torino, Torino, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.03.029DOI Listing
August 2019

Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung.

Virchows Arch 2019 Jun 15. Epub 2019 Jun 15.

Pathology Division of the Department of Oncology, University of Turin, San Luigi Hospital, Regione Gonzole 10, Orbassano, 10043, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-019-02596-8DOI Listing
June 2019

Long-term disease control in a metastatic squamous cell carcinoma of the oral cavity treated with maintenance metronomic capecitabine.

J Oncol Pharm Pract 2019 05 1:1078155219845433. Epub 2019 May 1.

Medical Oncology, Department of Oncology, University of Turin, Azienda Ospedaliera Universitaria San Luigi Gonzaga, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219845433DOI Listing
May 2019

Honoring the Past, Embracing the Present, You Are the Future.

J Thorac Oncol 2019 Apr 6;14(4):571-573. Epub 2019 Mar 6.

International Association for the Study of Lung Cancer. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.01.012DOI Listing
April 2019

Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma.

Semin Oncol 2019 Apr 18;46(2):145-154. Epub 2019 Jun 18.

Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.06.001DOI Listing
April 2019

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.

Cancer Treat Rev 2019 Mar 7;74:35-42. Epub 2019 Jan 7.

Departmental Unit of Clinical and Experimental Uro-Andrologic Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.01.002DOI Listing
March 2019

The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients.

Cancers (Basel) 2018 Dec 24;11(1). Epub 2018 Dec 24.

Medical Oncology, University of Torino; Department of Oncology, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/11/1/18
Publisher Site
http://dx.doi.org/10.3390/cancers11010018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356835PMC
December 2018

Pemetrexed, Vitamin B12, and Thoracic Tumors: The Times, They Are A-Changin'.

Clin Lung Cancer 2018 11 2;19(6):461-463. Epub 2018 Aug 2.

Department of Oncology, University of Torino, Torino, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.07.007DOI Listing
November 2018

Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences.

Cancer Treat Rev 2018 Sep 20;69:215-223. Epub 2018 Jul 20.

Radiation Oncology, San Luigi Gonzaga Hospital, Department of Oncology, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.07.010DOI Listing
September 2018

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?

Future Oncol 2018 May 27;14(12):1223-1231. Epub 2018 Apr 27.

Department of Oncology, AOU San Luigi di Orbassano, University of Torino, Regione Gonzole, 10, 10043 Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0627DOI Listing
May 2018

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.

Int J Clin Oncol 2018 Apr 27;23(2):281-286. Epub 2017 Sep 27.

Division of Medical Oncology, Department of Oncology, AOU San Luigi di Orbassano, University of Torino, Regione Gonzole 10, Orbassano, 10043, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-017-1195-xDOI Listing
April 2018

Hormonal treatment and quality of life of prostate cancer patients: new evidence.

Minerva Urol Nefrol 2018 Apr 14;70(2):144-151. Epub 2017 Dec 14.

Division of Medical Oncology, Ordine Mauriziano Hospital, Department of Oncology, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0393-2249.17.03066-1DOI Listing
April 2018

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.

BMC Cancer 2018 04 26;18(1):470. Epub 2018 Apr 26.

Medical Oncology, Department of Oncology, University of Turin, Azienda Ospedaliera Universitaria San Luigi, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4395-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918988PMC
April 2018

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives.

Biomed Res Int 2017 7;2017:5618174. Epub 2017 Jun 7.

Department of Oncology, University of Turin, Division of Medical Oncology, Ordine Mauriziano Hospital, Via Magellano 1, 10028 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/5618174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478823PMC
March 2018

Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer.

Endocr Relat Cancer 2018 01 28;25(1):R1-R9. Epub 2017 Sep 28.

Division of Medical OncologyOrdine Mauriziano Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0355DOI Listing
January 2018

Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?

Cancer Treat Rev 2017 Dec 25;61:70-81. Epub 2017 Oct 25.

Innovative Cancer Medicine Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372173015
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2017.10.003DOI Listing
December 2017

Implementation of precision medicine in clinical trials in thoracic oncology: Which are the hurdles?

Cancer 2017 12 10;123(24):4764-4766. Epub 2017 Nov 10.

Department of Oncology, University of Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31055DOI Listing
December 2017

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

J Clin Oncol 2017 Nov 11;35(31):3591-3600. Epub 2017 Sep 11.

Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.9012DOI Listing
November 2017

Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.

Endocr Relat Cancer 2017 07 21;24(7):319-327. Epub 2017 Apr 21.

Department of OncologyUniversity of Turin, Pathology Unit, City of Health and Science Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0095DOI Listing
July 2017

Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma.

Endocr Pathol 2017 Jun;28(2):95-102

Department of Clinical and Biological Sciences and Department of Oncology, University of Turin at San Luigi Hospital, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-017-9473-8DOI Listing
June 2017

Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.

Acta Oncol 2017 Apr 9;56(4):555-562. Epub 2017 Jan 9.

a Division of Medical Oncology, Department of Oncology , University of Turin, San Luigi Gonzaga Hospital , Turin , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2016.1260772DOI Listing
April 2017

Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.

Cancer Treat Rev 2017 Mar 11;54:1-9. Epub 2017 Jan 11.

Division of Medical Oncology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.01.002DOI Listing
March 2017

Lung cancer: current therapies and new targeted treatments.

Lancet 2017 01 27;389(10066):299-311. Epub 2016 Aug 27.

Medical Oncology Department, Hospital Universitario Doce de Octubre and CNIO, Madrid, Spain.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://dx.doi.org/10.1016/S0140-6736(16)30958-8DOI Listing
January 2017

Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?

Expert Rev Anticancer Ther 2016 Oct 1;16(10):1053-62. Epub 2016 Sep 1.

b Division of Medical Oncology, Department of Oncology , University of Turin, Mauriziano Hospital , Turin , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2016.1227706DOI Listing
October 2016

Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.

J Clin Oncol 2016 08 18;34(24):2866-73. Epub 2016 Jul 18.

Lucio Crinò, University Medical School of Perugia, Azienda Ospedale Perugia, Perugia; Filippo De Marinis, European Institute of Oncology, Milan; Giorgio Scagliotti, University of Torino, Torino, Italy; Myung-Ju Ahn, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Heather Wakelee, Stanford University Medical Center, Stanford, CA; Toyoaki Hida, Aichi Cancer Center, Nagoya; Makoto Nishio, Japanese Foundation for Cancer Research, Tokyo, Japan; Tony Mok, Chinese University of Hong Kong, Shatin, China; David Spigel, Sarah Cannon Research Institute, Nashville, TN; Enriqueta Felip, Vall d'Hebron University, Barcelona, Spain; Fabrice Branle and Massimiliano Quadrigli, Novartis Pharma AG, Basel, Switzerland; Chetachi Emeremni and Jie Zhang, Novartis Pharma, East Hanover, NJ; and Alice T. Shaw, Massachusetts General Hospital, Boston MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.65.5936
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.65.5936DOI Listing
August 2016

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Eur Urol 2016 Apr 28;69(4):563-573. Epub 2015 Sep 28.

Division of Medical Oncology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.09.013DOI Listing
April 2016

Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.

Neuroendocrinology 2015 16;101(3):246-55. Epub 2015 Mar 16.

Department of Oncology, San Luigi Hospital, University of Turin, Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000381454DOI Listing
March 2016

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer.

Cancer Treat Rev 2016 Mar 12;44:61-73. Epub 2016 Feb 12.

Division of Medical Oncology, Department of Oncology, University of Turin at San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.02.002DOI Listing
March 2016

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer.

Transl Lung Cancer Res 2016 Feb;5(1):89-91

Department of Oncology, University of Torino, "San Luigi Gonzaga" Hospital, Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.07.18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758972PMC
February 2016

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer.

Cancer Treat Rev 2015 Dec 31;41(10):884-92. Epub 2015 Aug 31.

Department of Oncology, Medical Oncology, University of Turin at San Luigi Hospital, Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2015.08.002DOI Listing
December 2015

Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.

Hum Pathol 2015 Dec 11;46(12):1799-807. Epub 2015 Sep 11.

Department of Oncology, University of Turin at San Luigi Hospital, Orbassano 10043, Turin, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2015.08.012DOI Listing
December 2015

Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature.

BMC Cancer 2015 Nov 18;15:914. Epub 2015 Nov 18.

Medical Oncology, Azienda Ospedaliera Universitaria San Luigi, Regione Gonzole 10, 10043, Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1923-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652398PMC
November 2015

Papillary renal cell carcinoma: A review of the current therapeutic landscape.

Crit Rev Oncol Hematol 2015 Oct 27;96(1):100-12. Epub 2015 May 27.

University of Torino, Department of Oncology, Torino, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.05.008DOI Listing
October 2015

Metastatic castration-resistant prostate cancer: time for innovation.

Future Oncol 2015 ;11(1):91-106

University of Turin, Department of Oncology, S Luigi Hospital, Division of Medical Oncology, Regione Gonzole, 10, 10043 - Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.145DOI Listing
September 2015

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.

Endocrine 2015 Sep 15;50(1):223-30. Epub 2015 Jan 15.

Department of Oncology, Medical Oncology, University of Turin at San Luigi Hospital, Regione Gonzole 10, 10043, Orbassano, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-015-0525-xDOI Listing
September 2015

Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

J Clin Oncol 2015 Aug 13;33(24):2667-74. Epub 2015 Jul 13.

Giorgio Scagliotti and Silvia Novello, University of Turin, Orbassano, Torino; Adolfo Favaretto, Istituto Oncologico Veneto, Padova; Armando Santoro, Istituto Clinico Humanitas, Milan, Italy; Joachim von Pawel, Asklepios-Fachkliniken München-Gauting, Munich, Germany; Rodryg Ramlau, Poznań University of Medical Sciences, Poznań, Poland; Fabrice Barlesi, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France; Wallace Akerley, Huntsman Cancer Institute, Salt Lake City, UT; Sergey Orlov, St Petersburg State Medical University, St Petersburg, Russian Federation; David Spigel, Clinical Locations, Nashville, TN; Vera Hirsh, McGill University Health Centre, Montreal, Quebec; Frances A. Shepherd, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Lecia V. Sequist, Massachusetts General Hospital, Boston; Jeffrey S. Ross, Foundation Medicine, Cambridge; Brian Schwartz, ArQule, Woburn, MA; Alan Sandler, Genentech, San Francisco, CA; and Qiang Wang, Reinhard von Roemeling, and Dale Shuster, Daiichi Sankyo, Edison, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.7317DOI Listing
August 2015

ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.

Int J Cancer 2015 Jun 12;136(11):2598-609. Epub 2014 Nov 12.

Department of Oncology, University of Turin, S. Luigi Hospital, Regione Gonzole 10, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29302DOI Listing
June 2015

Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

J Thorac Oncol 2015 Mar;10(3):492-9

*Department of Oncology, University of Turin, Orbassano, Italy; †Pathology & Oncology Divisions, Saint Antonio and Biagio General Hospital, Alessandria, Italy; and ‡Istituto Superiore di Sanità, Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000436DOI Listing
March 2015

Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer.

Expert Rev Anticancer Ther 2014 Dec 3;14(12):1495-513. Epub 2014 Sep 3.

Department of Oncology, S. Luigi Hospital, University of Torino, Regione Gonzole 10, 10043 Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.949245DOI Listing
December 2014

ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance scheme.

J Thorac Oncol 2014 Oct;9(10):1470-6

*Center of Predictive Molecular Medicine, Center of Excellence on Aging, University-Foundation, Chieti, Italy; †Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; ‡Division of Anatomic Pathology, San Luigi Hospital and University of Turin, Orbassano, Italy; §Pathology Department, Policlinico di Modena, Modena, Italy; ‖Diagnostic and Laboratory Medicine, INT-Fondazione "G.Pascale", Naples, Italy; ¶Medical Oncology Unit, University Hospital, Parma, Italy; #Department of Medical Oncology, Perugia Hospital, Perugia, Italy; **Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy; ††Department of Human Pathology and Oncology, University of Florence, Florence, Italy; ‡‡Pathology Department, Casa di Cura San Pio X and I.R.C.C.S. Policlinico San Donato, Milano, Italy; §§Thoracic Oncology Unit, University of Torino, San Luigi Hospital, Torino, Italy; ‖‖Cell Biology and Biotherapy Unit, INT-Fondazione "G.Pascale", Naples, Italy; and ¶¶Medical Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000280DOI Listing
October 2014

Intermittent everolimus administration for malignant insulinoma.

Endocrinol Diabetes Metab Case Rep 2014 1;2014:140047. Epub 2014 Sep 1.

Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica Università di Brescia, Oncologia Medica, Azienda Ospedaliera Spedali Civili , Brescia , Italy.

View Article

Download full-text PDF

Source
https://edm.bioscientifica.com/view/journals/edm/2014/1/EDM1
Publisher Site
http://dx.doi.org/10.1530/EDM-14-0047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174591PMC
October 2014

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome.

J Thorac Oncol 2014 Oct;9(10):1540-6

*Department of Oncology, University of Turin at San Luigi Hospital, Orbassano, Torino; and †Division of Pathology, University of Modena, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000271DOI Listing
October 2014

MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.

Hum Pathol 2014 Aug 24;45(8):1555-62. Epub 2014 Apr 24.

Department of Oncology, University of Turin at San Luigi Hospital, Orbassano, 10043, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.04.005DOI Listing
August 2014

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.

Oncotarget 2014 Aug;5(15):6191-205

Laboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino, Italy; Interdepartmental Center "G. Scansetti" for Studies on Asbestos and other Toxic Particulates, University of Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171622PMC
http://dx.doi.org/10.18632/oncotarget.2186DOI Listing
August 2014

Motesanib plus carboplatin/paclitaxel in patients with advanced squamous non-small-cell lung cancer: results from the randomized controlled MONET1 study.

J Thorac Oncol 2014 Aug;9(8):1154-61

*Department of Oncology, University of Turin, San Luigi Hospital, Turin, Italy; †Thoracic Surgery Department, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine; ‡Sumy Regional Oncology Centre, Sumy State University, Sumy, Ukraine; §Centrul de Oncologie Medicala, Iasi, Romania; ‖Central Hospital Bad Berka, Bad Berka, Germany; ¶Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; #Department of Biostatistics & Epidemiology, Amgen Inc., South San Francisco; **Department of Oncology, Amgen Inc., Thousand Oaks, CA; and ††Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000227DOI Listing
August 2014

First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era.

Future Oncol 2014 May;10(6):1081-93

Department of Oncology, University of Turin, San Luigi Hospital, Regione Gonzole 10, 10043 Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon.13.247
Publisher Site
http://dx.doi.org/10.2217/fon.13.247DOI Listing
May 2014

An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer.

J Thorac Oncol 2013 Dec;8(12):1529-37

*Department of Clinical and Biological Sciences, University of Turin, Orbassano, Torino, Italy; †Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; ‡Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France; §Asklepios Clinic, Asklepios Fachkliniken München-Gauting, Gauting, Germany; ‖Department of Oncology, Herlev Hospital, Onkologisk afdeling, Herlev, Denmark; ¶Department of Thoracic Oncology, Hospital Grosshansdorf, Grosshansdorf, Germany; #Department of Respiratory Medicine, Centre Hospitalier Universitaire de Liege, Liege, Belgium; **Department of Respiratory Medicine, Hopital Saint-Antoine, Paris Cedex, France; ††Department of Medical Oncology, Hospital de Mataro, Mataro, Spain; and ‡‡Oncology Research and Development, GlaxoSmithKline, Research Triangle Park, North Carolina; Collegeville, Philadelphia, Pennsylvania; and Uxbridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000005DOI Listing
December 2013

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

J Clin Oncol 2013 Nov 30;31(32):4140-7. Epub 2013 Sep 30.

Juan Sandoval, Jesus Mendez-Gonzalez, F. Javier Carmona, Sergi Sayols, Sebastian Moran, Holger Heyn, Miguel Vizoso, Antonio Gomez, Montse Sanchez-Cespedes, and Manel Esteller, Bellvitge Biomedical Research Institute; Josefina Mora, Hospital de la Santa Creu i Sant Pau; Manel Esteller, University of Barcelona and Institucio Catalana de Recerca i Estudis Avançats, Barcelona; Miquel Taron and Rafael Rosell, Catalan Institute of Oncology, Badalona, Catalonia; Marina Pollan, Instituto de Salud Carlos III, Madrid; Maria J. Pajares and Luis M. Montuenga, University of Navarra; Wenceslao Torre, Clínica University de Navarra, Pamplona, Spain; Ernest Nadal, Guoan Chen, and David G. Beer, University of Michigan Medical School, Ann Arbor, MI; Yassen Assenov and Fabian Müller, Max Planck Institute, Saarbrücken, Germany; Christoph Bock, Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Lucia A. Muscarella, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Triantafillos Liloglou, Michael Davies, and John K. Field, The University of Liverpool Cancer Research Centre, Liverpool, United Kingdom; Elisabeth Brambilla, Centre Hospitalier Universitaire A Michallon, Grenoble, France; Luca Roz, IRCCS Foundation National Cancer Institute, Milan; Marco Lo Iacono and Giorgio V. Scagliotti, University of Torino, Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5516DOI Listing
November 2013